Trials / Completed
CompletedNCT07076628
Respiratory Depression of Remimazolam vs. Propofol for Monitored Anesthesia Care
Incidence of Respiratory Depression of Remimazolam Compared With Propofol for Monitored Anesthesia Care During Hysteroscopy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- DongGuk University · Academic / Other
- Sex
- Female
- Age
- 19 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The comparison of incidence of respiratory depression between remimazolam and propofol under monitored anesthesia care for hysteroscopic surgery
Detailed description
* Non-invasive blood pressure, electrocardiogram, and oxygen saturation sensors are attached. * Wear an oxygen mask (5L per minute), and place the sampling line for end-tidal carbon dioxide partial pressure measurement inside the nose. * Check the randomization table to determine the drug to be administered, and prepare propofol or remimazolam accordingly. * Record the baseline values (0 min). * Start administration of Remifentanil. ⑥ Administer anesthesia to adjust the maintenance dose to reach a sedation level of 2 or less on the MOAA/S scale. ⑦ Adjust the remifentanil dose according to the patient's response ⑧ When the target sedation level is reached, the surgical preparation process and surgery begin, and the study variables are observed and recorded at 5-minute intervals. ⑨ Stop drug administration upon end of surgery. ⑩ After confirming proper recovery of consciousness and spontaneous breathing, leave the recovery room. ⑪ Before leaving the recovery room, check the complete recovery and investigate the patient's satisfaction with anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Propofol | Propofol infusion with remifentanil |
| DRUG | Remimazolam | Remimazolam infusion with remifentanil |
Timeline
- Start date
- 2023-08-24
- Primary completion
- 2025-05-30
- Completion
- 2025-05-30
- First posted
- 2025-07-22
- Last updated
- 2025-07-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07076628. Inclusion in this directory is not an endorsement.